Newsroom | 12302 results

Sorted by: Latest

Medical Supplies
-

Smart Meter and eClinicalWorks More Than Double RPM Adoption in 2025, Powering a New Era of Connected Care for Patients

TAMPA, Fla.--(BUSINESS WIRE)--Smart Meter, the leader in Cellular RPM™ and the nation’s most trusted source of patient-generated vital health data, announced exceptional momentum in its integration and partnership with eClinicalWorks, one of the largest AI-powered ambulatory EHR platforms in the country. So far in 2025, the partnership has driven a 107% year-over-year increase in active Smart Meter devices used by eClinicalWorks (eCW) providers — now surpassing 25,000 active devices in the mark...
-

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas Medical Branch (UTMB Health) demonstrating the positive impact of smart infusion pump integration with hospital electronic medical records (EMRs) on patient safety, clinicians' bedside productivity and programming compliance. The analyses of more than one million infusions on Baxter’s Spectrum IQ l...
-

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year results for the period ended September 30, 2025, along with a number of important recent achievements and highlights. Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon has made significant progress as a company to close out our fiscal year 2025...
-

Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026...
-

Healthcare Leaders, Peers and Industry Experts Share Challenges and Spark Collaborative Solutions at HealthTrust Connect

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance GroupSM, a leading performance improvement organization with an exclusive membership of 1,800+ hospitals and 85,000+ non-acute sites of care, held its annual HealthTrust Connect conference in Nashville, TN, on November 3, 2025. The event brought together 400+ industry experts, members, project teams, trade partners and facility managers to collaborate and explore real-world applications for products and services. “True to the conference...
-

Thomas Jefferson University and Sempresto, Inc. Announce Strategic Partnership to Advance Smartphone-Integrated Rescue Medication Platform

PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Thomas Jefferson University (TJU) and Sempresto, Inc. today announced a broad strategic partnership, expanding upon Sempresto’s existing exclusive license from Jefferson for groundbreaking platform technology invented by Edmund Pribitkin, MD, MBA, FACS. Dr. Pribitkin serves as Chief Physician Executive and EVP at Jefferson Health, Professor in the Department of Otolaryngology–Head & Neck Surgery, and chairs Sempresto’s Scientific Advisory Board. Inspi...
-

Syntax Bio Receives Award from Breakthrough T1D to Advance Pancreatic Beta Cell Therapy for Type 1 Diabetes

CHICAGO & NEW YORK--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, under its Industry Discovery and Development Partnership (IDDP) program to advance a pancreatic beta cell therapy targeting T1D using its Cellgorithm platform technology. “The daily burden for those living with t...
-

Biomaterial Wound Dressing Market Intelligence Report 2025-2030: Demand Drivers, Growth Challenges, Emerging Trends, Profiles of Major Players - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biomaterial Wound Dressing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The Global Biomaterial Wound Dressing Market, valued at USD 1.24 Billion in 2024, is projected to experience a CAGR of 8.94% to reach USD 2.07 Billion by 2030. The market's expansion is fundamentally propelled by the increasing global prevalence of chronic diseases, including diabetes and cardiovascular...
-

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

NEW YORK--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the “Company”) from Teleflex Incorporated (NYSE: TFX) for $1.5 billion in a carve-out transaction. For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used across fast-growin...
-

Morris & Dickson LLC Signs Letter of Intent to Acquire Prodigy Health

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson, the nation’s largest independent wholesale and specialty distributor, today announced that it has signed a non-binding Letter of Intent (LOI) to acquire Prodigy Health, a privately held, national specialty distributor of plasma derivatives, specialty drugs and vaccines. The proposed acquisition underscores Morris & Dickson’s accelerated growth in serving both inpatient and outpatient care settings for health systems, hospitals and prov...